Bsure Medical was founded in 2020, and has a strategic alliance with the multinational company FAGRON, Bsure's industrial partner and investor.
Bsure operates in the biotechnology sector and its first product is a genetic kit for the prediction of severe adverse reactions to subcutaneous implants (Dermal Fillers).
